BDBM19260 Tiazofurin Adenine Dinucleotide (TAD) Analogue, 30::[({[(2R,3S,4R,5R)-5-{6-amino-2-[(2-phenylethyl)amino]-9H-purin-9-yl}-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4R,5R)-5-(4-carbamoyl-1,3-thiazol-2-yl)-3,4-dihydroxyoxolan-2-yl]methoxy})phosphinic acid

SMILES: NC(=O)c1csc(n1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)nc(NCCc4ccccc4)nc23)[C@@H](O)[C@H]1O

InChI Key: InChIKey=QLYRXWWSIKZTOZ-JCNQHCNQSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 19260   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Inosine Monophosphate Dehydrogenase Type 1 (IMPDH1) (Homo sapiens (Human))	BDBM19260 (Tiazofurin Adenine Dinucleotide (TAD) Analogue, 30...) Show SMILES NC(=O)c1csc(n1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)nc(NCCc4ccccc4)nc23)[C@@H](O)[C@H]1O |r| Show InChI InChI=1S/C27H34N8O14P2S/c28-22-16-24(34-27(33-22)30-7-6-12-4-2-1-3-5-12)35(11-31-16)26-20(39)18(37)15(48-26)9-46-51(43,44)49-50(41,42)45-8-14-17(36)19(38)21(47-14)25-32-13(10-52-25)23(29)40/h1-5,10-11,14-15,17-21,26,36-39H,6-9H2,(H2,29,40)(H,41,42)(H,43,44)(H3,28,30,33,34)/t14-,15-,17-,18-,19-,20-,21-,26-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	73	-9.73	n/a	n/a	n/a	n/a	n/a	8.0	25
University of Minnesota at Twin Citiies					Assay Description Inhibition assays were performed in duplicate using two different concentrations of human IMPDH type 1 (87 and 155 nM) and varying concentrations of ...				J Med Chem 50: 5743-5751 (2007) Article DOI: 10.1021/jm070568j BindingDB Entry DOI: 10.7270/Q2RX99CT
					More data for this Ligand-Target Pair
Inosine Monophosphate Dehydrogenase Type 2 (IMPDH2) (Homo sapiens (Human))	BDBM19260 (Tiazofurin Adenine Dinucleotide (TAD) Analogue, 30...) Show SMILES NC(=O)c1csc(n1)[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)n2cnc3c(N)nc(NCCc4ccccc4)nc23)[C@@H](O)[C@H]1O |r| Show InChI InChI=1S/C27H34N8O14P2S/c28-22-16-24(34-27(33-22)30-7-6-12-4-2-1-3-5-12)35(11-31-16)26-20(39)18(37)15(48-26)9-46-51(43,44)49-50(41,42)45-8-14-17(36)19(38)21(47-14)25-32-13(10-52-25)23(29)40/h1-5,10-11,14-15,17-21,26,36-39H,6-9H2,(H2,29,40)(H,41,42)(H,43,44)(H3,28,30,33,34)/t14-,15-,17-,18-,19-,20-,21-,26-/m1/s1	PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	Article PubMed	255	-8.99	n/a	n/a	n/a	n/a	n/a	8.0	25
University of Minnesota at Twin Citiies					Assay Description Inhibition assays were performed in duplicate using two different concentrations of human IMPDH type 2 (33 and 66 nM) and varying concentrations of i...				J Med Chem 50: 5743-5751 (2007) Article DOI: 10.1021/jm070568j BindingDB Entry DOI: 10.7270/Q2RX99CT
					More data for this Ligand-Target Pair